Pro golfers headline Moffitt Cancer Center Benefit at Innisbrook Copperhead Course
Feb 01, 2007
PALM HARBOR, FL (April 2, 2007). -- Golf enthusiasts will enjoy an once-in-a-lifetime opportunity to play 18 holes with PGA and LPGA tour professionals at the Myelodysplastic Syndromes Foundation—H. Lee Moffitt Cancer Center Charity Golf Tournament for MDS on Monday, February 19, 2007. Event registration will begin at 8:30 a.m. at the Innisbrook Copperhead Golf Course on U.S. 19 in Palm Harbor. Special events include a Sunday evening VIP Pairings Party at 6 p.m. , a Putting Contest, a golf clinic with small group instruction given by the PGA professionals, a chance to mingle with the pros, lunch, and dinner with a celebrity. A shotgun start will take place on Monday at 11 a.m. Ticket and sponsorship information are available online at http://www.mdsgolftournament.golfreg.com/.###
Bruce Fleisher of the PGA Champions Tour will host the event and be joined by other PGA and LPGA professionals including Curtis Strange, Amy Alcott, Donna Caponi, Jim Thorpe, Bob Murphy, Bob Toski, Mark Lye, John Mahaffey, Dave Eichelberger, and Joe Theismann. Proceeds from the tournament will help to fund MDS research and patient advocacy at Tampa’s Moffitt Cancer Center & Research Institute and the MDS Foundation in Crosswicks, New Jersey.
MDS is a relatively unknown, but fatal group of bone marrow diseases. It is the most common of all the hematological malignancies with more than 30,000
new cases each year in the United States. Despite more than three decades of
dedicated research by epidemiologists, clinician researchers and scientists, the
causes of MDS remain largely unknown.
Because of its mission to contribute to the prevention and cure of cancer, the Moffitt Cancer Center has teamed up with the MDS Foundation to raise funds for research into the causes and cure of MDS. This partnership will benefit the MDS Foundation’s Young Investigator Grants Program and will provide research funding for Dr. Alan F. List, deputy physician-in-chief and lead hematological malignancies’ researcher at the H. Lee Moffitt Cancer Center & Research Institute.
In 2001, H. Lee Moffitt Cancer Center & Research Institute earned NCI Comprehensive Cancer Center status in recognition of its excellence in research and contributions to clinical trials, prevention and cancer control. Additionally, Moffitt is a member of the National Comprehensive Cancer Network, a prestigious alliance of the country's leading cancer centers, and is listed in the U.S. News & World Report among “America’s Best Hospitals” for cancer. Moffitt’s sole mission is to contribute to the prevention and cure of cancer.